Anavex Life Sciences (AVXL) Return on Capital Employed (2017 - 2022)

Anavex Life Sciences' Return on Capital Employed history runs 6 years deep, the most recent figure standing at 31.36% for Q2 2022.

• In Q2 2022, Return on Capital Employed changed N/A year-over-year to 31.36%; the TTM figure through Jun 2022 stood at 31.36% (changed N/A YoY), while the FY2021 annual figure was 48.12%, up 8925.0% from the prior year.
• Return on Capital Employed came in at 31.36% for Q2 2022 at Anavex Life Sciences, down from 29.87% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 24.57% in Q3 2021 to a low of 154.64% in Q2 2019.
• A 5-year average of 84.28% and a median of 75.96% in 2018 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed sank 8217 bps in 2019 and surged 7728 bps in 2021, its largest moves.
• Anavex Life Sciences' Return on Capital Employed stood at 103.97% in 2018, then decreased by 9 bps to 112.97% in 2019, then jumped by 33 bps to 75.46% in 2020, then surged by 63 bps to 27.95% in 2021, then decreased by 12 bps to 31.36% in 2022.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 31.36%, 29.87%, and 27.95% for Q2 2022, Q1 2022, and Q4 2021 respectively.

Peer Comparison